By Dan Michaels

BRUSSELS--The European Union's health agency said it had found possible links between AstraZeneca PLC's Covid-19 vaccine and rare blood clots but said the shot's benefits continue to outweigh potential risks. The European Medicines Agency found no specific risk factors linking the vaccine to the clots.

Write to Dan Michaels at dan.michaels@wsj.com

(END) Dow Jones Newswires

04-07-21 1030ET